Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.1% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
1451
DELISTED
Faro Technologies
FARO
| $6.83M | 0.01% |
127,342
+121,342
| +2,022% | +$6.36M |
|
|
UFS
1452
DELISTED
DOMTAR CORPORATION (New)
UFS
| $6.82M | 0.01% |
+323,242
| New | +$7.02M |
|
|
ENLC
1453
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $6.81M | 0.01% |
2,791,238
-644,667
| -19% | -$1.33M |
|
1454
Core Laboratories
CLB
$488M
| $6.8M | 0.01% |
334,448
-315,552
| -49% | -$5.66M |
|
1455
Banc of California
BANC
$3.03B
| $6.79M | 0.01% |
627,353
-130,400
| -17% | -$1.31M |
|
1456
Brookfield Renewable
BEP
$9.97B
| $6.79M | 0.01% |
265,954
-279,920
| -51% | -$7.03M |
|
1457
Caesarstone
CSTE
$72.3M
| $6.79M | 0.01% |
572,678
+197,060
| +52% | +$2.07M |
|
|
AGTC
1458
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $6.77M | 0.01% |
1,222,240
-176,469
| -13% | -$808K |
|
|
HONE
1459
DELISTED
HarborOne Bancorp
HONE
| $6.75M | 0.01% |
790,335
-6,700
| -0.8% | -$53.6K |
|
1460
GSI Technology
GSIT
$215M
| $6.74M | 0.01% |
938,846
+5,700
| +0.6% | +$41.4K |
|
|
OTIC
1461
DELISTED
Otonomy, Inc.
OTIC
| $6.7M | 0.01% |
1,850,865
-72,100
| -4% | -$188K |
|
|
FLIR
1462
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $6.68M | 0.01% |
164,660
-32,611
| -17% | -$1.35M |
|
1463
Evolution Petroleum
EPM
$132M
| $6.68M | 0.01% |
2,385,172
-8,000
| -0.3% | -$21.5K |
|
1464
MillerKnoll
MLKN
$1.53B
| $6.66M | 0.01% |
281,965
+107,200
| +61% | +$2.42M |
|
1465
InMode
INMD
$870M
| $6.65M | 0.01% |
469,362
+295,762
| +170% | +$3.96M |
|
1466
Ceragon Networks
CRNT
$197M
| $6.64M | 0.01% |
3,087,200
-211,300
| -6% | -$444K |
|
1467
Seres Therapeutics
MCRB
$46.8M
| $6.63M | 0.01% |
69,665
+15,825
| +29% | +$1.39M |
|
1468
Nasdaq
NDAQ
$52.7B
| $6.63M | 0.01% |
166,500
-119,148
| -42% | -$4.44M |
|
1469
STMicroelectronics
STM
$46.7B
| $6.63M | 0.01% |
243,570
-274,054
| -53% | -$6.81M |
|
|
CBD
1470
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $6.62M | 0.01% |
506,700
+365,500
| +259% | +$4.41M |
|
|
SPNE
1471
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $6.6M | 0.01% |
630,500
-21,500
| -3% | -$220K |
|
1472
iShares Gold Trust
IAU
$62.9B
| $6.57M | 0.01% |
+193,350
| New | +$6.34M |
|
1473
Cerence
CRNC
$385M
| $6.55M | 0.01% |
+160,300
| New | +$4.6M |
|
1474
iShares MBS ETF
MBB
$38.9B
| $6.54M | 0.01% |
59,100
+21,100
| +56% | +$2.34M |
|
1475
YPF
YPF
$206B
| $6.53M | 0.01% |
1,136,153
+994,418
| +702% | +$4.64M |
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.